Posted On: 06/10/2014 10:48:39 AM
Post# of 94315
$AMBS Recent News
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:23 p.m. May 20, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: AMARANTUS BIOSCIENCE HOLDINGS, INC. 6:04 a.m. April 22, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: AMARANTUS BIOSCIENCE HOLDINGS, INC. 6:58 a.m. April 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Still Several Reasons To Remain Long Amarantus 9:30 a.m. April 9, 2014 - Seeking Alpha
New Cash To Help Drive Amarantus Pipeline 11:13 a.m. Feb. 18, 2014 - Seeking Alpha
What The Amarantus Super Bowl Campaign Can Teach Us About SodaStream 9:36 a.m. Feb. 6, 2014 - Seeking Alpha
Amarantus' ADHD drug performs well in Phase IIa study 10:32 a.m. Feb. 4, 2014 - Seeking Alpha
Amarantus Licenses Phase 2b Ready Eltoprazine For PD-LID 11:19 a.m. Jan. 14, 2014 - Seeking Alpha
An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases 2:03 p.m. Jan. 7, 2014 - Seeking Alpha
3 Approaches To Retinitis Pigmentosa 11:36 a.m. Jan. 2, 2014 - Seeking Alpha
Amarantus Fundamentals Are Improving 11:27 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:24 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus' LymPro May Be More Crucial For Alzheimer's Treatment Than We Think 8:38 a.m. Oct. 25, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:08 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Initiating Coverage Of Amarantus - Credibility vs. Perception - Analyst Blog 1:10 p.m. May 23, 2013 - Zacks.com
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 11:27 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus to Present at LD Micro Invitational on June 4th 9:37 a.m. June 2, 2014 - GlobeNewswire
OTC Sector Trading Focus List: GrowBlox Sciences, Inc., Amarantus Bioscience Holdings, Inc., Plandai Biotechnology, Inc., Limitless Venture Group, Inc., Infinex Ventures, Inc. 9:23 a.m. June 2, 2014 - PR Newswire - PRF
Amarantus to Present at the 3rd Annual Marcum MicroCap Conference 8:29 a.m. May 27, 2014 - GlobeNewswire
Super Stock Profits Top Five OTC Focus List: Kirin International Holding, Inc. Frozen Food Gift Group, Gray Fox Petroleum Corp, Amarantus Bioscience Holdings, Propanc Health Group Corporation 9:23 a.m. May 22, 2014 - PR Newswire - PRF
Amarantus Reports First Quarter 2014 Financial Results 8:01 a.m. May 21, 2014 - GlobeNewswire
Amarantus to Present at the 15th Annual B. Riley & Co. Investor Conference 8:59 a.m. May 12, 2014 - GlobeNewswire
Amarantus and Brewer Sports Announce 3rd #C4CT Concussion Awareness Summit Focused on TBI-Induced Alzheimer's 8:02 a.m. May 7, 2014 - GlobeNewswire
Amarantus Establishes Office in Geneva, Switzerland 8:35 a.m. May 6, 2014 - GlobeNewswire
Amarantus Acquires Additional Rights to LymPro Test From Memory Dx 2:02 p.m. May 5, 2014 - GlobeNewswire
Amarantus Announces Positive Independent Peer-Reviewed Preclinical Data for MANF in Alzheimer's and Diabetes 11:46 a.m. May 1, 2014 - GlobeNewswire
Amarantus CSO to Present on PhenoGuard Data at Astrocytes in Health and Neurodegenerative Disease in London 8:31 a.m. April 28, 2014 - GlobeNewswire
Amarantus Appoints Dr. Charlotte Keywood Chief Medical Officer of Its Therapeutics Division 6:01 a.m. April 8, 2014 - GlobeNewswire
Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer 6:01 a.m. April 1, 2014 - GlobeNewswire
Amarantus Bioscience Holdings, Inc. - "Commercialization On-Track for 2014: Updating LymPro Test(R) Progress" 11:41 a.m. March 31, 2014 - ACCESSWIRE
Amarantus Appoints Dr. Louis Kirby to Board of Advisors 8:31 a.m. March 31, 2014 - GlobeNewswire
Cavendish Selects Amarantus to Present at the Cavendish Global Health Impact Forum 8:01 a.m. March 26, 2014 - GlobeNewswire
Amarantus BioScience Holdings, Inc. "Transformational Funding Positions Amarantus Heading into 2014 Milestones" 1:46 p.m. March 10, 2014 - ACCESSWIRE
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC 6:00 a.m. March 10, 2014 - GlobeNewswire
Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity 8:25 a.m. March 6, 2014 - GlobeNewswire
Amarantus Outlines MANF Research Collaboration Strategy 1:01 p.m. March 3, 2014 - GlobeNewswire
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:23 p.m. May 20, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: AMARANTUS BIOSCIENCE HOLDINGS, INC. 6:04 a.m. April 22, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: AMARANTUS BIOSCIENCE HOLDINGS, INC. 6:58 a.m. April 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Still Several Reasons To Remain Long Amarantus 9:30 a.m. April 9, 2014 - Seeking Alpha
New Cash To Help Drive Amarantus Pipeline 11:13 a.m. Feb. 18, 2014 - Seeking Alpha
What The Amarantus Super Bowl Campaign Can Teach Us About SodaStream 9:36 a.m. Feb. 6, 2014 - Seeking Alpha
Amarantus' ADHD drug performs well in Phase IIa study 10:32 a.m. Feb. 4, 2014 - Seeking Alpha
Amarantus Licenses Phase 2b Ready Eltoprazine For PD-LID 11:19 a.m. Jan. 14, 2014 - Seeking Alpha
An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases 2:03 p.m. Jan. 7, 2014 - Seeking Alpha
3 Approaches To Retinitis Pigmentosa 11:36 a.m. Jan. 2, 2014 - Seeking Alpha
Amarantus Fundamentals Are Improving 11:27 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:24 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus' LymPro May Be More Crucial For Alzheimer's Treatment Than We Think 8:38 a.m. Oct. 25, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:08 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Initiating Coverage Of Amarantus - Credibility vs. Perception - Analyst Blog 1:10 p.m. May 23, 2013 - Zacks.com
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 11:27 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus to Present at LD Micro Invitational on June 4th 9:37 a.m. June 2, 2014 - GlobeNewswire
OTC Sector Trading Focus List: GrowBlox Sciences, Inc., Amarantus Bioscience Holdings, Inc., Plandai Biotechnology, Inc., Limitless Venture Group, Inc., Infinex Ventures, Inc. 9:23 a.m. June 2, 2014 - PR Newswire - PRF
Amarantus to Present at the 3rd Annual Marcum MicroCap Conference 8:29 a.m. May 27, 2014 - GlobeNewswire
Super Stock Profits Top Five OTC Focus List: Kirin International Holding, Inc. Frozen Food Gift Group, Gray Fox Petroleum Corp, Amarantus Bioscience Holdings, Propanc Health Group Corporation 9:23 a.m. May 22, 2014 - PR Newswire - PRF
Amarantus Reports First Quarter 2014 Financial Results 8:01 a.m. May 21, 2014 - GlobeNewswire
Amarantus to Present at the 15th Annual B. Riley & Co. Investor Conference 8:59 a.m. May 12, 2014 - GlobeNewswire
Amarantus and Brewer Sports Announce 3rd #C4CT Concussion Awareness Summit Focused on TBI-Induced Alzheimer's 8:02 a.m. May 7, 2014 - GlobeNewswire
Amarantus Establishes Office in Geneva, Switzerland 8:35 a.m. May 6, 2014 - GlobeNewswire
Amarantus Acquires Additional Rights to LymPro Test From Memory Dx 2:02 p.m. May 5, 2014 - GlobeNewswire
Amarantus Announces Positive Independent Peer-Reviewed Preclinical Data for MANF in Alzheimer's and Diabetes 11:46 a.m. May 1, 2014 - GlobeNewswire
Amarantus CSO to Present on PhenoGuard Data at Astrocytes in Health and Neurodegenerative Disease in London 8:31 a.m. April 28, 2014 - GlobeNewswire
Amarantus Appoints Dr. Charlotte Keywood Chief Medical Officer of Its Therapeutics Division 6:01 a.m. April 8, 2014 - GlobeNewswire
Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer 6:01 a.m. April 1, 2014 - GlobeNewswire
Amarantus Bioscience Holdings, Inc. - "Commercialization On-Track for 2014: Updating LymPro Test(R) Progress" 11:41 a.m. March 31, 2014 - ACCESSWIRE
Amarantus Appoints Dr. Louis Kirby to Board of Advisors 8:31 a.m. March 31, 2014 - GlobeNewswire
Cavendish Selects Amarantus to Present at the Cavendish Global Health Impact Forum 8:01 a.m. March 26, 2014 - GlobeNewswire
Amarantus BioScience Holdings, Inc. "Transformational Funding Positions Amarantus Heading into 2014 Milestones" 1:46 p.m. March 10, 2014 - ACCESSWIRE
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC 6:00 a.m. March 10, 2014 - GlobeNewswire
Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity 8:25 a.m. March 6, 2014 - GlobeNewswire
Amarantus Outlines MANF Research Collaboration Strategy 1:01 p.m. March 3, 2014 - GlobeNewswire
(0)
(0)
